Shopping Cart
- Remove All
- Your shopping cart is currently empty
(Z)-KC02 is an ABHD16A inhibitor which targets the enzyme responsible for producing lysophosphatidylserine (lyso-PS), a lipid involved in regulating immune and neurological functions. This compound is linked to the mitigation of neurological disorders, including retinitis pigmentosa and cataracts (PHARC), by depleting lyso-PS in lymphoblasts from affected individuals. Moreover, (Z)-KC02 diminishes lyso-PS levels and lipopolysaccharide-induced cytokine production in macrophages and influences lyso-PS metabolism in vivo [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 μg | $110 | 35 days | |
500 μg | $458 | 35 days | |
1 mg | $748 | 35 days |
Description | (Z)-KC02 is an ABHD16A inhibitor which targets the enzyme responsible for producing lysophosphatidylserine (lyso-PS), a lipid involved in regulating immune and neurological functions. This compound is linked to the mitigation of neurological disorders, including retinitis pigmentosa and cataracts (PHARC), by depleting lyso-PS in lymphoblasts from affected individuals. Moreover, (Z)-KC02 diminishes lyso-PS levels and lipopolysaccharide-induced cytokine production in macrophages and influences lyso-PS metabolism in vivo [1]. |
In vitro | (Z)-KC02 disrupts ABHD16A in murine macrophages, thereby reducing lyso-PS levels [1]. |
Molecular Weight | 287.35 |
Formula | C17H21NO3 |
Cas No. | 1646795-60-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.